65-- NM - New Mexico ESFO - Telazol Vials
140FS225Q0190 · INTERIOR, DEPARTMENT OF THE
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
NM - New Mexico ESFO - Chemical Immobilization Drug (Telazol) for Mexican Wolf Recovery Program
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | $17K | 1 | 2026-07-02 |
| COVERMYMEDS PHARMACY LLC | $16K | 1 | 2026-07-02 |
| PRIORITY HEALTHCARE DISTRIBUTION INC | $16K | 1 | 2026-07-02 |
| THERACOM, L.L.C. | $38K | 1 | 2026-07-02 |
| SRI INTERNATIONAL | $49.9M | 7 | 2026-07-02 |
Questions
What is solicitation 140FS225Q0190?
65-- NM - New Mexico ESFO - Telazol Vials, issued by INTERIOR, DEPARTMENT OF THE, under NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING).
What do similar contracts close for?
Comparable closed awards in this category ran from $16K to $49.9M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.